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 ABSTRACT 
 
Purpose 
 
To provide an up-to-date estimate on the changing prevalence of stroke survivors, and 
examines the geographic and socioeconomic variations in low and middle-income 
countries (LMICs). 
 
Methods  
We searched MEDLINE, EMBASE, SCOPUS and Web of Science databases and 
systematically reviewed articles reporting stroke prevalence and risk factors from 
inception to July, 2015. Pooled prevalence estimates and secular trends based on 
random-effect models were conducted across LMICs, World Bank regions and income 
groups 
 
Results 
Overall, 101 eligible community-based studies were included in the meta-analysis. 
The pooled crude prevalence of stroke survivors was highest in Latin America and 
Caribbean (21.2 per 1000, 95% CI 13.7 to 30.29) but lowest in sub-Saharan Africa 
(3.5 per 1000, 95% CI 1.9 to 5.7). Steepest increase in stroke prevalence occurred in 
low-income countries, increasing by 14.3% annually  while the lowest increase 
occurred in  lower-middle income countries (6% annually), and for every 10 years 
increase in participants’ mean age, the prevalence of stroke survivors increases by 
62% (95% CI 6% to 147%).  
 
Conclusion 
The prevalence estimates of stroke survivors are significantly different across LMICs 
in both magnitude and secular trend.  Improved stroke surveillance and care, as well as 
for better management of the underlying risk factors, primarily undetected or 
uncontrolled high blood pressure (HBP) are needed. 
 
 
Key Words: Stroke Survivors, Prevalence, Secular trends; Low-and middle-income   
countries; World Bank regions 
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1.0 Introduction 
Recent global estimates found that stroke ranked as the second commonest cause of death 
with 5.9 million stroke-related deaths in 2010 [1]. This number is expected to increase to 7.8 
million by 2030 in the absence of significant global public health response [2]. Despite the 
infectious disease scourge, low-and middle-income countries (LMICs) account for over 78% 
disability adjusted life years (DALYs) from stroke, which is at least 7 times the DALYs lost 
in high-income countries [1]. Disentangling the drivers of global mortality and morbidity has 
led to targeted regional and national investments in cardiovascular health resulting in about 
40% reduction of stroke burden between 1970 and 2008 in high income countries [3]. 
Surprisingly, the trend is the opposite in LMICs with a rise of over 100% of stroke prevalence 
within the same period [3]. The increase and changing pattern of stroke prevalence in LMICs 
has mostly been attributed to rapid economic development and combined effects of 
demographic (particularly population growth and ageing), epidemiological and nutritional 
transitions currently occurring [4]. As the global population older than 65 years of age 
continues to increase by approximately 9 million people per year in LIMCs, this predicts a 
higher stroke prevalence with increase burden particularly in Asia and Latin America [5]. 
Though there are existing reviews that had looked at prevalence of stroke in LMICs and 
regions such as Africa and Latin America [6-9], to the best of our knowledge there is no 
recent attempt to compile studies on stroke prevalence across different geographic regions in 
LMICs. Since the publication of these reviews, there have been an increasing number of new 
studies from these regions. This study therefore, aimed to provide more accurate estimates on 
the prevalence of stroke survivors and secular trends in LMICs in order to inform decision 
regarding policy responses and public health intervention across many geographic regions, 
socioeconomic and populations’ subgroups. 
 
2. Methods 
2.1 Protocol and registration 
This systematic review rational and methods were specified in advance and documented in a 
protocol which was published in the PROSPERO register (CRD42014015129) [10] 
 
2.2 Search strategy and data extraction 
We conducted a thorough literature search to identify relevant studies on stroke prevalence in 
LMICs.  Electronic databases of MEDLINE, EMBASE, SCOPUS and Web of Science were 
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searched from inception to July, 2015 without any language restriction. Relevant journals and 
reference lists of included primary articles were also scrutinized for additional studies that 
could have been omitted from the database searches. The following combinations of 
controlled review terms and keywords covering the study characteristics were used. These 
include: outcomes; "stroke", “cerebrovascular disease", “cerebrovascular accident", “brain 
infarction”, “brain stem infarctions”, “cerebral infarction,” study design; "surveillance”, 
“survey”, “population based”, “community based", and low-and middle-income countries; 
including all individual countries (Supplementary Table 1).  
 
2.3 Data extraction and eligibility criteria 
Three authors (ME, AE and EB) evaluated the eligibility of studies obtained from the 
literature search using a predefined protocol. They independently extracted, compared and 
merged the data on studies that met the selection criteria. In cases of discrepancy, agreement 
was reached by consensus. We included only community-based studies that reported 
prevalence of stroke ‘survivors’ and conducted in LMICs as defined by World Bank [11]. We 
also included only studies that used WHO’s definition of stroke, ‘‘rapidly developing clinical 
signs of focal (or global) disturbance of cerebral function lasting longer than 24 hour, unless 
interrupted by death, with no apparent cause other than that of vascular origin’’[12], however, 
we allowed less rigorous case ascertainment due to inadequate facilities in most LMICs. 
Studies that reported prevalence of stroke using some elements of the Sudlow–Warlow 
criteria [13]  for stroke incidence were also included.  
2.4 Assessment of methodological quality 
Two authors (ME and AE) independently evaluated the methodological and reporting quality 
of each study using the modified version of Newcastle-Ottawa Scale (Supplementary Table 
2). Essentially, we graded the risk of bias in each study as low, moderate, high or unclear  
according to five study areas namely; selection of participants (selection bias),  sample size, 
detection instrument (outcome measurement tool), adjustment for confounding and 
(controlled)  and detection accuracy. Publication bias using funnel plots and Egger’s test was 
also conducted on the pooled studies  
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2.5 Statistical analysis 
For the meta-analysis, we first stabilized the raw prevalence of stroke from each study using 
the Freeman-Tukey variant of the arcsine square root transformed proportion [14] suitable for 
pooling. We used a DerSimonian-Laird random effects model [15] due to anticipated 
variations in study population, health care delivery systems and stage of epidemic transition. 
We performed leave-one-study-out sensitivity analysis to determine the stability of the 
results. This analysis evaluated the influence of individual studies by estimating the pooled 
stroke prevalence in the absence of each study [16].  We assessed heterogeneity among 
studies by inspecting the forest plots and using the chi-squared test for heterogeneity with a 
10% level of statistical significance, and using the I2 statistic where we interpret a  value of 
50% as representing moderate heterogeneity [17, 18]. We assessed the possibility of 
publication bias by evaluating a funnel plot for asymmetry. Because graphical evaluation can 
be subjective, we also conducted a Egger’s regression asymmetry test [19] as formal 
statistical tests for publication bias. 
 
We explored the effect of study-level factors on the overall pooled stroke prevalence 
estimates using sub-group and meta-regression analyses. Univariate and multivariate random-
effects logistic regression analyses were conducted to investigate the impact of study-level 
factors on the pooled stroke prevalence. Univariate random-effects logistic regression 
analyses were used to investigate the bivariate relationship between each study-level factors 
and prevalence of stroke estimates. Multivariate random-effects logistic regression analyses 
were carried out to determine which study-level factors were independently associated with 
prevalence of stroke estimates. Only factors statistically significant in the univariate models 
were included in the multivariate model. Meta-analysis results were reported as combined 
stroke prevalence with 95% confidence intervals (CIs), while meta-regression results are 
reported as odds ratio with 95% CIs. All P values are exact and P<.05 was considered 
significant. Analyses were conducted using Stata version 14 for Windows (Stata Corp, 
College Station, Texas). This systematic review was performed according to the Preferred 
Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guideline [20, 21] 
PRISMA checklist is provided in the Supplementary Table 3.  
 
2.6 Trend analysis 
We examined time trends in the stroke prevalence estimates from 1970 to 2014 using Poisson 
regression models with the absolute cases of stroke as the outcome variable and the calendar 
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year of the publication as the predictor.  This method allows for estimation of time trends 
across individual calendar years to obtain average annual percentage change (AAPC), 
assuming that the rate of change is at a constant rate of the previous year [22]. The Poisson 
regression procedure fits a model of the following form: 
   )log(log 10 sizesampleybbcasesy                               (1) 
where ‘cases’ equals number of stroke cases reported per year, log is the natural log, b0 is the 
intercept, b1 is the trend, y is the year – year is given as 0, 1, 2, … 14 (year 0 is 1970, year 1 
is 1971, and so on to 2014), and log of ‘sample size’ was entered as the offset. The AAPC 
was calculated using the following formula: 
 
                                                
 1 1 100bAAPC e  
                                                                (2) 
3. Results  
3.1 Study selection and characteristics of the included studies 
The process of study selection is shown in Fig.1. Overall, the literature search of databases 
yielded 1,877 articles. The titles and abstracts of these were screened for relevance and 1,718 
were excluded as duplicates, non-relevant titles and abstracts. 159 articles were selected for 
critical reading. In all, 101 articles with a total of 7,909,976 participants from 34 LMICs were 
included. The characteristics of the included studies are summarised in Supplementary Tables 
4 to 10. The studies were published between 1970 and 2014, and sample size ranged from 
500 to as much as 258,576. All the studies are community-based employing a door-to door, 
multi-stage or simple random sampling technique. Each of the study covered at least one part 
of the WHO STEPS stroke protocol for case ascertainment [23]. We found that 39 studies 
(38.6%) that employed cranial computed tomography (CT) or magnetic resonance imaging 
(MRI) have a low risk of bias in stroke diagnosis, while 62 (61.4%) studies were limited by 
availability of resources and neurological imaging, however, rigorous and detailed 
epidemiological exercise of self-reported diagnosis of stroke in these groups were validated 
through neurological examination by a specialist team. Most of the studies were conducted in 
a single site in the rural, urban settings or both. Only two studies were conducted in multiple 
sites in different countries [24, 25]. When reported, the mean age of participants ranged from 
25 years to 78 years. The median percentage of male participants was 48% (range: 31% to 
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82%). The median percentage of participants with known hypertension was 36% (range: 6 to 
71%).  
 
3.2 Risk of bias of included studies 
Summary of risk of bias assessment for each study is shown in Supplementary Table 11. The    
risk of bias in the selection of participants is low in most studies (n=98, 97%) and moderate in 
three studies (3%). The risk of bias due to sample size or number of participants included in 
the studies was low in most studies (n=83, 83%), high in seventeen studies (17%) and unclear 
in one study. The risk of detection bias due to inadequate outcome assessment was low, about 
three-quarter of the studies (n=77, 76%) and high in the remaining studies (n=24, 24%).  
 
3.3 Variations in Stroke prevalence by geographical regions 
3.3.1 East Asia and Pacific  
Prevalence of stroke ‘survivors’ and 95% CIs from individual studies with a pooled estimate 
are shown in Fig.3 and Supplementary Fig. 1. The reported stroke prevalence ranged from 
4.27 (per 1000 population) to as much as 162 (per 1000 population). The pooled prevalence 
(‘annualised year average’) of stroke for all studies yielded an estimate of 19.9 (95% 14.7 to 
25.9 per 1000 population). There was no evidence of publication bias (P = 0.058 for Egger's 
regression asymmetry test). The results of leave-one-study-out sensitivity analyses showed 
that no study had undue influence on pooled stroke prevalence (Supplementary Fig. 3).  
3.3.2 Europe and Central Asia 
Prevalence of stroke ‘survivors’ and 95% CIs from individual studies with a pooled estimate 
are shown in Fig. 3 and Supplementary Fig. 4. The reported stroke prevalence ranged from 9 
per 1000 population in Turkey to 33 per 1000 population in Romania. The pooled prevalence 
(‘annualised year average’) of stroke for all studies yielded an estimate of 19.5 (95% 3.2 to 
49.1 per 1000 population).  
3.3.3 Latin America and Caribbean  
Prevalence of stroke ‘survivors’ and 95% CIs from individual studies with a pooled estimate 
are shown in Fig. 3 and Supplementary Fig. 5.  The reported stroke prevalence ranged from 
1.5 (per 1000 population) to as much as 54.2 (per 1000 population). The pooled prevalence 
(‘annualised year average’) of stroke for all studies yielded an estimate of 21.2 (95% 13.7 to 
30.3 per 1000 population). There was no evidence of no evidence of publication bias (P = 
0.053 for Egger's regression asymmetry test). The results of leave-one-study-out sensitivity 
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analyses showed that no study had undue influence on pooled stroke prevalence 
(Supplementary Fig. 7).  
3.3.4 Middle East and North Africa  
Prevalence of stroke ‘survivors’ and 95% CIs from individual studies with a pooled estimate 
are shown in Fig. 3 and Supplementary Fig. 8. The reported stroke prevalence ranged from 
1.20 (per 1000 population) to 10.8 (per 1000 population). The pooled prevalence (‘annualised 
year average’) of stroke for all studies yielded an estimate of 5·6 (95% 4.0 to 7.5 per 1000 
population). There was no evidence of publication bias (P = 0.917 for Egger's regression 
asymmetry test). The results of leave-one-study-out sensitivity analyses showed that no study 
had undue influence on pooled stroke prevalence (Supplementary Fig. 10).  
3.3.5 South Asia  
Prevalence of stroke ‘survivors’ and 95% CIs from individual studies with a pooled estimate 
are shown in Fig.3 and Supplementary Fig. 11. The reported stroke prevalence ranged from 
0.5 (per 1000 population) to as much as 191 (per 1000 population). The pooled prevalence 
(‘annualised year average’) of stroke for all studies yielded an estimate of 9.4 (95% 6.7 to 
12.6 per 1000 population). There was no evidence of publication bias (P = 0.928 for Egger's 
regression asymmetry test). The results of leave-one-study-out sensitivity analyses showed 
that no study had undue influence on pooled stroke prevalence (Supplementary Fig. 13).  
3.3.6 Sub-Saharan Africa 
Prevalence of stroke ‘survivors’ and 95% CIs from individual studies with a pooled estimate 
are shown in Fig. 3 and Supplementary Fig. 14. The reported stroke prevalence ranged from 
0.15 (per 1000 population) to as much as 24.2 (per 1000 population). The pooled prevalence 
(‘annualised year average’) of stroke for all studies yielded an estimate of 3.5 (95% 1.9 to 5.7 
per 1000 population). There was no evidence of publication bias (P = 0.945 for Egger's 
regression asymmetry test). The results of leave-one-study-out sensitivity analyses showed 
that no study had undue influence on pooled stroke prevalence (Supplementary Fig. 16).   
3.4 Variations in Stroke prevalence by country’s income categories 
As shown in Fig. 3, the pooled prevalence stroke ‘survivors’ was highest in upper-middle 
income countries (20.9, 95% CI 17.0 to 25.2 per 1000, 57 studies) followed by lower 
middle-income countries (6.9, 95% CI 5.4 to 8.6 per 1000, 37 studies) and closely by low-
income countries (6.0, 95% CI 2.1 to 11.8 per 1000, 7 studies).    
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3.5 Secular trend in the prevalence of stroke survivors 
Secular trend in stroke prevalence by different geographic region is shown in Fig. 4. We 
observed a continuous increase in prevalence of stroke across all geographic regions. The 
increase is more pronounced in Latin America and Caribbean (trend = 0·157, p value = 
0.0001) followed East Asia and Pacific (trend = 0.125, p value = 0.0001) and sub-Saharan 
Africa countries (trend = 0.113, p value = 0·0001), such that prevalence of stroke have been 
increasing annually by 17.0%, 13.3% and 12.0% respectively.  As shown in Fig. 5, we 
observed a continuous increase in the stroke prevalence across the countries’ income 
categories. Over the past three decades, the stroke prevalence has increased annually by 
14.3% (trend = 0.134, p value = 0.0001) in low-incomes countries, by 12% in upper-middle 
income countries (trend = 0.113, p value = 0.0001) and by 5.8% in lower-middle income 
countries (trend = 0.057, p value = 0.0001). Though the prevalence of stroke has been lowest 
in low-income countries, over time, it recorded the steepest increase and have already 
overtaken the lower-middle and upper-middle-income countries.   
3.6 Factors modifying prevalence of stroke estimates  
The result of study-level factors associated with prevalence of stroke is shown in Table 1. In 
the adjusted analyses, study’s geographic region, income category, publication year, 
participants’ mean age, and percentage male were statistically significantly associated with 
stroke prevalence estimates. Prevalence estimates from East Asia and Pacific and Latin 
America and Caribbean were six times higher than those from sub-Saharan Africa. Similarly, 
stroke prevalence from upper-middle income countries was as four times as high as those 
from low-income countries. Stroke prevalence from urban areas was twice as high as those 
from rural areas. For every 10 years increase in participants’ mean age, the stroke prevalence 
increases by 84% (OR = 1.84, 95% CI 1.46 to 2.32) (Supplementary Fig. 18). For every 10% 
increase in the percentage of male participants included in the study, the stroke prevalence 
decreases by 68% (OR = 0.32, 95% CI 0.22 to 0.47) (Supplementary Fig. 19). Variations in 
the mean age of the participants explained almost half of the between studies variation in 
stroke prevalence estimates (49%).  
Year of publication, percentage male, and sample size each explained almost one-third in the 
between studies variation in stroke prevalence estimates. However, in the adjusted analysis, 
when all study-level factors that were significant in unadjusted analyses were controlled for 
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statistically, only mean age of the participants remained statistically significant with the 
prevalence of stroke estimates (OR- 1.62, 95% CI 1.06 to 2.47).  
4. Discussion 
Stroke prevalence varied significantly across geographical regions in different time period. 
Low-income countries particularly in sub-Saharan African have low prevalence of stroke 
survivors. This may have been due to the high fatality rates from stroke owing to less 
investment in health care, increased poverty and co-morbidities like HIV/AIDS and 
Tuberculosis [26-28]. The early stage of epidemiological transition characterised by 
hypertensive heart disease and a huge proportion of haemorrhagic stroke disease are now 
occurring in these countries [29]. Pooled estimate of stroke in upper-middle-income countries 
is about 3-fold higher as against lower-middle-income or low-income countries. These 
differences are not surprising, however, the increasing levels of affluence and urbanization 
[30] and the rise in life expectancy [30] and associated risk factors [4, 25] particularly 
hypertension provide a plausible explanation. In fact, there is a large body of epidemiological 
evidence on the high prevalence of undetected or poorly managed hypertension in LMICs, 
which is likely to play a major role in the huge prevalence of stroke in these settings [25]. 
 
We observed a continuous increase in the stroke prevalence across the three countries’ 
income categories. Over the past three decades, the stroke prevalence has increased annually 
by 14.3% (trend = 0.134, p value = 0.0001) in low-incomes countries, 12% in upper-middle 
income countries (trend = 0.113, p value = 0.0001) and by 5.8% in lower-middle income 
countries (trend = 0.057, p value = 0.0001). Though, the prevalence of stroke has been 
highest in upper-middle income countries, however, low-income countries record the 
steepest increase in stroke prevalence and projected to overtake both lower-middle and 
upper-middle- income countries. The changing prevalence of stroke survivors is quite 
revealing, and suggests a major epidemiological and demographic shift. Other common 
themes found within the periods indicate a low prevalent rate from 1970-1989, however, 
there are few exceptions where the rate had increased significantly and reached a plateau 
from 1983 and 1988 [31-33]. Between 1990 and 2007, data from China [34], Columbia [35, 
36] and Romania [37] showed a net increase in prevalence. This increases several folds from 
2010 to 2014 particularly in China [32, 38, 39] Brazil [30, 40, 41] and Cuba [42], suggesting 
a combination of rapid socioeconomic changes including increase in aging population, 
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urbanization, and lifestyle factors. Latin America faces major demographic changes; the 
most important being urbanization (almost 90% of the population now live in urban areas) 
and aging; that is, the ratio of productive adults to elderly individuals is steadily shrinking 
[5, 8]. In Brazil for instance, socio-economic developments that have occurred over the past 
decades is well-known. Other factors may include access to vascular prevention strategies, 
exposure to risk factors and inequality to basic medical care particularly in the rural 
communities [41]. 
 
This review apart from the evidentiary underpinning of the significantly higher prevalence 
of stroke, revealed some important issues including the preponderance of traditional risk 
factors. For every 10 years increase in participants’ mean age, the stroke prevalence 
increases by 62%.  The pattern of age-specific increase in stroke prevalence is clearly 
marked within three age-brackets for both genders with available data. Our result show 
that Latin America and Caribbean region has the highest proportion of elderly (≥65 years) 
participants living in urban areas.  This corroborated the recent evidence of 
epidemiological transition in Latin America toward older urban dwelling adults [8]. The 
higher proportion of stroke in upper-middle-income countries and urban settings compared 
to low-income countries and rural environments as shown in the present study and in 
previous reviews [6, 8, 43] are in line with convergence of increasing income level, 
urbanisation and cardio-vascular disease predictors.  
The most recent reviews on stroke epidemiology were limited to 7 incidence studies in 9 
LMICs [9]. Previous reviews had little  representation of LMICs [44], others were based on 
regional [6, 8, 45-48], country [28, 49, 50] or population-specific analysis [28, 49, 50]. There 
are also global reviews of stroke with few studies in LMICs [1, 44]. Given the limited number 
of studies, geographical spreads and omission of important development indicators, it appears 
that these reports may not necessarily reflect the true prevalence estimate of stroke survivors 
in LMICs in the current epidemiological and demographic transitions. For instance, Feign  
and co-authors (2014),  in a recent  report on the global burden of stroke reported a 
prevalence estimates of 393.4/100,000 population  in 2010[1]. The result was comparable 
with the current estimate, which further underpins a near representation of the size of the 
problem in LMICs. However, the minor differences may probably be due to the study 
periods, age groups and fewer data-points (the report provided data for only 34 population-
studies for LMICs). In addition, the result of stroke prevalence in Africa reported a continent-
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wide pooled estimate without due consideration of human development index and gross 
national income per capita estimates [6, 51]. Our study presents the most comprehensive and 
up-to-date review of stroke prevalence in LMICs. Moreover, the introduction of World Bank 
regions and income groups in our analytical model provided interesting dimension to warrant 
valid comparative estimate appropriate for public health policy interventions on the 
prevalence of stroke survivors within these jurisdictions. 
To date, the health priorities of many LMICs particularly in sub-Saharan Africa and south 
Asian countries remain infectious diseases mainly HIV/AIDS, Malaria and Tuberculosis [52-
54]. This is in addition to high poverty, malnutrition, illiteracy, unsafe drinking water and 
social discrimination [55]. The economic impact of increased stroke survivors in our study 
would mean growing underinvestment and GDP loses reflecting increased loss in productivity 
and reduced labour efficiency in LMICs.                    
Cost for stroke survivors was estimated to be as high as $34 billion annually in the United 
States[56], and about  5% of total NHS cost amounting to £8.9billion in the UK [57]. Studies 
on the cost of stroke in LMICs are few and far between, in Togo for instance, the estimated 
direct cost per person stood at 936 Euros in only 17 days, about 170 times more than the 
average annual heath expenditure of a Togolese [58]. This does not include informal and 
indirect costs.  Such financial outlay in stroke alone would foreclose the consideration of 
urgent priority public health issues in LMICs. 
Consistent evidence from our study and elsewhere found that hypertension is the main risk 
factor of all stroke in LMICs and this is more prominent among the young adults who present 
with stroke unaware of their high blood pressure status [59]. With the steepest increase in the 
prevalence of stroke survivors taking place in LMICs particularly in low-income countries, 
options for urgent and improved surveillance and cost-effective prevention of major risk-
factors such as hypertension remain an important public health priority. As a result of  the 
double burden of communicable and non-communicable diseases in LMICs [60], it appears 
the estimates found in this study will continue in an upward trend with huge fatality due to 
policy alignment focusing on the prevention and control of infectious diseases including 
maternal, perinatal and nutrition related conditions.   
While informative, the results of this meta-analysis should be interpreted with caution. 
First, in large continental region such as sub-Saharan Africa and Europe and Central Asia, 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
13 
 
there were insufficient studies to entirely represent the regions. In addition, we found 
significant difference related to study-level participants’ characteristics, publication year, 
and study sample size. Nevertheless, the results of tests for publication bias provided 
evidence that we are unlikely to have missed studies that could have altered the meta-
analyses results. The diagnosis of stroke in LMICs remains a huge challenge, hence, 
ascertainment of cases were not well defined across some studies and this has been 
reported previously [61]. We did not provide data on stroke-related disability or case-
fatality. Although such data are important for health-care planning, such estimates may be 
unreliable due to conflicting information on causes of death, overlapping disabilities caused 
by disorders that accompany stroke in many older patients and the fact that  majority of 
stroke survivors do not access the health service due to prohibitive out-of-pocket expenses, 
distance to urban hospital and lack of stroke functioning units in rural health care settings 
[44, 62]. Some hospital surveys in south Asia and  sub-Saharan Africa have shown that CT 
scans for instance, were only conducted on less than half of patients presenting with stroke, 
and this is mainly among those that can afford it [62]. Nonetheless, we allowed studies 
showing quality methodological rigour including detailed epidemiological exercise in our 
final analysis.  
Despite these limitations, the study’s strengths are important. We conducted a meta-analysis 
as a preferable option for data synthesis, since qualitative or narrative synthesis can  lead to 
misleading conclusions that should not be generalized beyond the scope of the analysis [63]. 
Comprehensive searches of databases were also conducted to ensure that all relevant 
publications were identified. We also reduced potential bias in the conduct of this review by 
having the authors independently scan through the search output and extract the data. In 
addition, we included only community-based studies and provided estimates on stroke 
prevalence trends. These provided additional information for local feedback on health system 
and public-health demands.   
 
5. Conclusions 
 Our study findings provide contemporary estimates that reflect the significant prevalence of 
stroke survivors in LMICs. The socio-economic implication of stroke in LMICs is very high 
in terms of magnitude and secular trend. Though upper-middle income countries accounts for 
the largest prevalence of stroke, low-income countries have experienced the steepest increase 
in stroke prevalence over the last three decades, and are projected to overtake both lower-
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middle and upper-middle- income countries.  The findings of the study will be useful for 
proper design of stroke screening (including high blood pressure and other predictors), 
treatment, rehabilitation, and related public health prevention strategies. Particular attention 
should be given to the large prevalence of undetected or uncontrolled high blood pressure [6, 
25, 64], which is likely to play a major role in the observed secular trends in stroke 
prevalence across low-resource settings. 
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TABLE 
Table 1 Results of meta-regression analyses 
 Unadjusted (Univariate)  Adjusted (Multivariate)* 
Variable OR (95% CI) P-value R2  OR (95% CI) P-value 
Region   17.1    
East Asia & Pacific 5.95 (2.43 to 14.59) 0.0001   2.03 (0.37 to 11.11) 0.395 
Europe & central   Asia 7.01 (1.00 to 48.73) 0.049   1.19 (0.17 to 8.42) 0.858 
Latin America & Caribbean 6.11 (2.54 to 14.69) 0.000   1.83 (0.37 to 9.12) 0.442 
Middle East & North Africa 2.05 (0.67 to 6.32) 0.207   1.29 (0.18 to 9.40) 0.791 
South Asia 2.39 (0.94 to 6.05) 0.066   5.21 (0.86 to 31.36) 0.069 
Sub-Saharan Africa 1 (reference)    1 (reference)  
Country income   16.4  ni  
Low 1 (reference)    1 (reference)  
Low-middle 1.25 (0.43 to 3.59) 0.677   3.19 (0.54 to 18.83) 0·187 
Upper-middle 3.94 (1.14 to 10.98) 0.009   3.12 (0.49 to 19.92) 0.213 
Study design   0.0  ni  
Cohort 1 (reference)      
Cross-sectional 0.94 (0.31 to 2.80) 0.910     
Setting   2.9  ni  
Rural 1 (reference)      
Urban 2.13 (1.09 to 4.18) 0.028     
Rural & urban  1.34 (0.68 to 2.94) 0.393     
Publication year 1.08 (1.06 to 1.11) 0.0001 28.0  1.04 (0.92 to 1.16) 0.523 
Sample size (log) 0.65 (0.57 to 0.75) 0.0001 28.6  0.96 (0.61 to 1.50) 0.839 
Mean age (per 10 year) 1.84 (1.46 to 2.32) 0.0001 49.2  1.62 (1.06 to 2.47) 0.027 
Percentage male (per 10%) 0.32 (0.22 to 0.47) 0.0001 30.4  0.77 (0.37 to 1.61) 0.462 
Hypertensive (per 10%) 1.29 (0.98 to 1.68) 0·.064 11·.3  ni  
Smokers (per 10%) 1.52 (0.87 to 2·.68) 0.131 9.7  ni  
ni: not included, OR: Odds ratio; CI: Confidence Interval 
*Explained variance (52.5%) 
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Fig. 1. Study selection process and flow 
 
1877 Articles identified 
from relevant 
databases  
840 articles screened for 
studies that met the 
inclusion criteria 
681 Non-relevant titles and 
abstracts 
194 full text studies 
assessed for further 
eligibility 
101 Studies included in the 
review and meta-analysis 
93 Studies Excluded: 
29 Review studies 
20 Studies from high-income countries 
14 Studies are risk factors only 
24 Hospital-based studies 
3 Studies without any suitable translators 
1 Studies not available in full text  
2 Study combined Stroke and TIA 
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1037 articles removed as 
duplicates 
35 Articles identified 
from reference list 
and other sources 
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Fig. 2. Study selection process and flow 
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Fig. 3. Pooled stroke prevalence by different subgroups 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
24 
 
Fig. 4. Secular trends in prevalence of stroke survivors by different geographic 
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Fig. 5. Secular trends in prevalence of stroke survivors by country’s income category 
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Highlights  
 101 community-based studies were identified and included in meta-analysis  
 Stroke survivors differ significantly in both magnitude and secular trend in LMICs 
 Highest annual increase of 14.3% occurred in low-income countries 
 Stroke surveillance and management of undetected or uncontrolled HBP should 
remain public health priority  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
e-component
Click here to download e-component: Supplementary Material  (JNS).doc
